|
Name |
Isodaucene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
6,8a-dimethyl-3-prop-1-en-2-yl-2,3,3a,4,5,8-hexahydro-1H-azulene
|
|
SMILES |
CC1=CCC2(CCC(C2CC1)C(=C)C)C
|
|
InChI |
InChI=1S/C15H24/c1-11(2)13-8-10-15(4)9-7-12(3)5-6-14(13)15/h7,13-14H,1,5-6,8-10H2,2-4H3
|
|
InChIKey |
RLNLRKHTQIXWHM-UHFFFAOYSA-N
|
|
Synonyms |
Isodaucene; (+)-Dauca-8,11-diene; Carota-4(5),11(12)-diene; Q67879952; (3S,3aS,8aR)-6,8a-Dimethyl-3-(prop-1-en-2-yl)-1,2,3,3a,4,5,8,8a-octahydroazulene; Azulene, 1,2,3,3a,4,7,8,8a-octahydro-3a,6-dimethyl-1-(1-methylethenyl)-, (1S,3aR,8aS)-; Azulene, 1,2,3,3a,4,7,8,8a-octahydro-3a,6-dimethyl-1-(1-methylethenyl)-, [1S-(1.alpha.,3a.alpha.,8a.beta.)]-
|
|
CAS | NA | |
PubChem CID | 73809332 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 5.1 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.518 |
Caco-2 Permeability: | -4.471 | MDCK Permeability: | 0.00001380 |
Pgp-inhibitor: | 0.062 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.814 |
30% Bioavailability (F30%): | 0.093 |
Blood-Brain-Barrier Penetration (BBB): | 0.645 | Plasma Protein Binding (PPB): | 94.87% |
Volume Distribution (VD): | 4.681 | Fu: | 4.19% |
CYP1A2-inhibitor: | 0.522 | CYP1A2-substrate: | 0.623 |
CYP2C19-inhibitor: | 0.325 | CYP2C19-substrate: | 0.918 |
CYP2C9-inhibitor: | 0.238 | CYP2C9-substrate: | 0.723 |
CYP2D6-inhibitor: | 0.042 | CYP2D6-substrate: | 0.872 |
CYP3A4-inhibitor: | 0.255 | CYP3A4-substrate: | 0.292 |
Clearance (CL): | 15.268 | Half-life (T1/2): | 0.075 |
hERG Blockers: | 0.045 | Human Hepatotoxicity (H-HT): | 0.528 |
Drug-inuced Liver Injury (DILI): | 0.139 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.045 | Maximum Recommended Daily Dose: | 0.561 |
Skin Sensitization: | 0.429 | Carcinogencity: | 0.532 |
Eye Corrosion: | 0.079 | Eye Irritation: | 0.605 |
Respiratory Toxicity: | 0.137 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002392 | 0.519 | D0O1UZ | 0.253 | ||||
ENC000786 | 0.519 | D04GJN | 0.253 | ||||
ENC003255 | 0.519 | D0K0EK | 0.250 | ||||
ENC002073 | 0.439 | D0F1UL | 0.250 | ||||
ENC000332 | 0.439 | D0B4RU | 0.250 | ||||
ENC001836 | 0.439 | D07BSQ | 0.250 | ||||
ENC000555 | 0.417 | D0D2VS | 0.244 | ||||
ENC001066 | 0.417 | D02CNR | 0.242 | ||||
ENC001565 | 0.414 | D04SFH | 0.239 | ||||
ENC001826 | 0.414 | D0I2SD | 0.239 |